Chemo-Free combo for lymphoma shows promise in early trial
Disease control
Terminated
This phase 2 trial tested a combination of two drugs, pembrolizumab (Keytruda) and rituximab (Truxima), in 22 people with marginal zone lymphoma, a type of blood cancer. The goal was to see if this chemotherapy-free approach could control the disease with fewer side effects than …
Phase: PHASE2 • Sponsor: University of Ulm • Aim: Disease control
Last updated Jun 22, 2026 11:56 UTC